week in cancer news

Healthy lifestyle habits can reduce risk of cancer, and less treatment may be adequate for some children with ALL.

by Marci A. Landsmann

Two studies on access to opioids identify disturbing patterns, and Keytruda before and after surgery helps some breast cancer patients.

by Kevin McLaughlin

A study measures the global impact of alcohol on cancer incidence, and the FDA approves treatments for multiple myeloma and urothelial cancer.

by Bradley Jones

Study shows cancer centers can improve coordination with physicians’ practices in their networks, and cancer death rates in U.S. continue to decline.

by Marci A. Landsmann

A study sheds light on the link between red meat consumption and colorectal cancer, and mRNA COVID-19 vaccines are effective in most cancer patients.

by Kevin McLaughlin

A reporter discusses the elevated risk for early-onset colorectal cancer in Black men, and a study shows that women are underrepresented in cancer clinical trials.

by Kate Yandell

A study compares the benefits of fixed doses of immunotherapy compared to weight-based doses, and the Food and Drug Administration approves a targeted therapy for a rare disorder called systemic mastocytosis.

by Bradley Jones

Triplet therapy shows promise for prostate cancer that was metastatic at diagnosis, and Americans report inadequate knowledge of palliative care.

by Marci A. Landsmann

A targeted therapy improves disease-free survival when given to people with certain hereditary mutations after breast cancer surgery, and the Food and Drug Administration approves a new lung cancer treatment targeting a mutated form of the KRAS protein.

by Kevin McLaughlin

A study finds that many people with solid tumors mount an antibody response following COVID-19 vaccination, and the Food and Drug Administration approves the first targeted therapy for a rare lung cancer subtype.

by Kate Yandell